Effect of HMB supplementation on body composition, fitness, hormonal profile and muscle damage indices

Journal of Pediatric Endocrinology and Metabolism

Volumn 23, Issue 7, 2010, Pages 641-650

  Portal, Shawn ^a,d   Eliakim, Alon ^b,c   Nemet, Dan ^b,c   Halevy, Orna ^d   Zadik, Zvi ^d,e  

^a WINGATE INSTITUTE   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Adolescent athlete; Ergogenic supplement; Fitness; HMB; IGF; Muscle anabolism; Muscle damage; Nutritional supplement; hydroxy methylbutyrate

Indexed keywords

2 OXOISOCAPROIC ACID; BETA HYDROXY BETA METHYLBUTYRATE; CHOLESTEROL; LEUCINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; BETA-HYDROXYISOVALERIC ACID; HUMAN GROWTH HORMONE; MUSCLE PROTEIN; SOMATOMEDIN C; VALERIC ACID DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; BODY COMPOSITION; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; FITNESS; HUMAN; MUSCLE CELL; MUSCLE INJURY; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; PHYSICAL PERFORMANCE; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; UNSPECIFIED SIDE EFFECT; APOPTOSIS; BLOOD; DRUG EFFECTS; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

APOPTOSIS; BODY COMPOSITION; DIETARY SUPPLEMENTS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MUSCLE PROTEINS; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL FITNESS; VALERATES;

EID: 77956538059     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2010.23.7.641     Document Type: Review

References (65)

1. Nemet D, Eliakim A. Protein and amino acid supplementation in sport. Int Sport Med J 2007; 8: 11-23.
2. Kreider RB, Almada AL, Antonio J, Breeder C, Earnest C, Greenwood L, Greenwood M, Incledon T, Kalman DS, Kerksick C, Kleiner SM, Leutholtz B, Lowery LM, Mendel R, Rasmussen CJ, Stout JR, Weir HP, Willoughby DS, Ziegenfuss TN. Exercise & sport nutrition: a balanced perspective for exercise physiologists. Professionalization in Exercise Physiology Online 2003.
3. Steven L, Nissen SL, Sharp RL. Effect of dietary Supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 2003; 94: 651-659.
4. Zadik Z, Nemet D, Eliakim A. Hormonal and metabolic effects of nutrition in athletes. J Ped Endocrinol Metab 2009; 22: 769-777.
5. Nemet D, Wolach B, Eliakim A. Proteins and amino acid supplementation in sports: are they truly necessary? Isr Med Assoc J 2005; 7: 328-332.
6. Dodge TL, Jaccard JJ. The effect of high school sports participation on the use of performance-enhancing substances in young adulthood. J Adolesc Health 2006; 39: 367-373.
7. Castillo EM, Comstock RD. Prevalence of use of performance-enhancing substances among United States adolescents. Pediatr Clin North Am 2007; 54: 663-675. (Pubitemid 47307355)
8. Mason MA, Giza M, Clayton L, Lonning J, Wilkerson RD. Use of nutritional supplements by high school football and volleyball players. Iowa Orthoped J 2001; 21: 43-48.
9. Chłopicka J, Wandas P, Zachwieja Z. Dietary supplements selected by young people exercising in fitness rooms in Kraków and environs. Rocz Panstw Zakl Hig 2007; 58: 185-189.
10. Koopman R, Wagenmakers AJ, Manders RJ, Zorenc AH, Senden JM, Gorselink M, Keizer HA, van Loon LJ. Combined ingestion of protein and free leucine with carbohydrate increases postexercise muscle protein synthesis in vivo in male subjects. Am J Physiol Endocrinol Metab 2005; 28: E645-E653. (Pubitemid 40397198)
11. Hider RC, Fern EB, London DR. Rel tionship between intracellular amino acids anc protein synthesis in the extensor digitorum longus muscle or rats. Biochem J 1969; 114: 171-178.
12. Nair KS, Swchartz RG, Welle S. Leucine as a regulator of whole body and skeletal music proyein metabolism in human. Am J Physiol 1992; 263: 928-934.
13. Van Kovering M, Nissen SL. Oxidation of leucine and alpha-ketoisocaproate to b-hydroxy-b-methlbutyrate in vivo. Am J Physiol Endocrinol Metab 1992; 262: 27-31
14. Bruzzone P, Siegel JH, Chiarla C, Wiles CE, Placko R, Goodarzi S. Leucine dose response in the reduction of urea production from septic proteolysis and in the stimulation of acute-phase proteins. Surgery 1991; 109: 768-778.
15. Frexes-Steed M, Lacy DB, Collins J, Abumrad NN. Role of leucine and other amino acids in regulating protein metabolism in vivo. Am J Physiol 1992; 262: 925-935.
16. Sapir DG, Walser M, Moyer ED, Rosenshein NB, Stewart PM, Moreadith C, Imbembo AL, Munoz S. Effects of a-ketoisocaproate and of leucine on nitrogen metabolism in postoperative patients. Lancet 1983; 1: 1010-1014. (Pubitemid 13126990)
17. Sax HC, Talamini MA, Fischer JE. Clinical use of branched-chain amino acids in liver disease, sepsis, trauma, and burns. Arch Surg 1986; 121: 358-366.
18. Nissen SL, Sharp R, Ray M, Rathmacher JA, Rice D, Fuller JC Jr, Connelly AS, Abumrad N. Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol 1996; 81: 2095-2104. (Pubitemid 26384538)
19. Wilson GJ, Wilson JM, Manninen AH. Effects of beta-hydroxy-beta- methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: a review. Nutr Metab (Lond) 2008; 3: 5:1.
20. Soares JMC, Povoas S, Neuparth MJ, Duarte JA. The effects of beta-hydroxy-beta-methylbuturate (HMB) on muscle atrophy induced by immobilization. Med Sci Sports Exerc 2001; 33: 140
21. Rathmacher JA, Zachwieja JJ, Smith SR, Lovejoy JL, Bray GA. The effect of the leucine metabolite β-hydroxy-β-methylbutyrate on lean body mass and muscle strength during prolonged bedrest. FASEB J 1999; 13: A909
22. Clark RH, Feleke G, Din M, Yasmin T, Singh G, Khan FA, Rathmacher JA. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. J Parenter Enteral Nutr 2000: 24: 133-139.
23. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 2002; 183: 471-479. (Pubitemid 34442515)
24. Baxter JH, Mukerji P, Voss AC, Tisdale MJ, Wheeler KB. Attenuating protein degradation and enhancing protein synthesis in skeletal muscle in stressed animal model systems. Med Sci Sports Exerc 2006; 38: S550-S551.
25. Flakoll P, Sharp R, Baier S, Levenhagen D, Carr C, Nissen S. Effect of beta-hydroxy-beta-methylbutyrate,ine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 2004; 20: 445-451.
26. Vukovich MD, Nancy B, Stubbs NB, Bohlken RM. Body composition in 70-year-old adults responds to dietary β-hydroxy-β-methylbutyrate similarly to that of young adults. Am Soc Nutr Sci 2001; 131(Suppl 7): 2049-2052.
27. Vukovich MD, Stubbs NB, Bohlken RM, Desch MF, Fuller JC, Rathmacher JA. The effect of dietary β- hydroxy-β-methylbutyrate (HMB) on strength gains and body composition changes in older adults. FASEB J 1997; 11: A376.
28. Panton L, Rathmacher J, Fuller J, Gammon J, Cannon L, Stettler S, Nissen S. Effect of β-hydroxy-β-methylbutyrate and resistance training on strength and functional ability in the elderly. Med Sci Sports Exerc 1998; 30: 194
29. Cohen DD. The effect of β-hydroxy-β-methylbutyrate (HMB) and resistance training on changes in body composition during positive and negative energy balance - a randomized double-blind study. MSc Thesis. St. Bartholomew's and Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London, London 1997.
30. Slater GJ, Jenkins D. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation and the promotion of muscle growth and strength. Sports Med 2000; 30: 115-116. (Pubitemid 30663607)
31. Kreider RB. Dietary supplements and the promotion of muscle growth with resistance exercise. Sports Med 1999; 27: 97-110.
32. Thomson JS. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation of resistance trained men. Asia Pac J Clin Nutr 2004; 13: S59
33. Gallagher PM, Carrithers JA, Godard MP, Schulze KE, Trappe SW. Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc 2000; 32: 2109-2115.
34. Vukovich MD, Dreifort GD. Effect of beta-hydroxy beta-methylbutyrate on the onset of blood lactate accumulation and V(O)(2) peak in endurance-trained cyclists. J Strength Cond Res 2001; 15: 491-497.
35. Lamboley CR, Royer D, Dionne IJ. Effects of beta-hydroxy-beta- methylbutyrate on aerobic-performance components and body composition in college students. Int J Sport Nutr Exerc Metab 2007; 17: 56-69.
36. O'Connor DM, Crowe MJ. Effects of beta-hydroxy-beta-methylbutyrate and creatine monohydrate supplementation on the aerobic and anaerobic capacity of highly trained athletes. J Sports Med Phys Fitness 2003; 43: 64-68.
37. Hoffman JR, Cooper J, Wendell M, Im J, Kang J. Effects of beta-hydroxy beta-methylbutyrate on power performance and indices of muscle damage and stress during high-intensity training. J Strength Cond Res 2004; 18: 747-752. (Pubitemid 39627313)
38. Thomson JS, Watson PE, Rowlands DS. Effects of nine weeks of beta-hydroxy-beta-methylbutyrate supplementation on strength and body composition in resistance trained men. J Strength Cond Res 2009; 23: 827-835.
39. Tiidus PM, Ianuzzo CD. Effects of intensity and duration of muscular exercise on delayed soreness and serum enzymes activities. Med Sci Sports Exerc 1983; 15: 461-465.
40. Knitter AE, Panton I, Rathmacher JA, Petersen A, Sharp R. Effects of β-hydroxy-β-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol 2000; 89: 1340-1344.
41. Wilson JM, Kim JS, Lee SR, Rathmacher JA, Dalmau B, Kingsley JD, Koch H, Manninen AH, Saadat R, Panton LB. Acute and timing effects of beta-hydroxy-beta-methylbutyrate (HMB) on indirect markers of skeletal muscle damage. Nutr Metab (Lond) 2009; 6: 6
42. Rowlands DS, Thomson JS. Effects of beta-hydroxy-beta-methylbutyrate supplementation during resistance training on strength, body composition, and muscle damage in trained and untrained young men: a meta-analysis. J Strength Cond Res 2009;23(Suppl 3): 836-846.
43. Bastiaanse EM, Hold KM, Van der Laarse A. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res 1997; 33: 272-283. (Pubitemid 27072629)
44. Pierno S, De Luca A, Tricarico D, Roselli A, Natuzzi F, Ferrannini E, Laico M, Camerino DC. Potential risk of myopathy by HMG-CoA reductase inhibitors: a comparison of pravastatin and simvastatin effects on membrane electrical properties of rat skeletal muscle fibers. J Pharmacol Exp Ther 1995; 275: 1490-1496. (Pubitemid 26129941)
45. Mutoh T, Kumano T, Nakagawa H, Kuriyama M. Role of tyrosine phosphorylation of phospholipase C gamma1 in the signaling pathway of HMG-CoA reductase inhibitor-induced cell death of L6 myoblasts. FEBS Lett 1999; 446: 91-94. (Pubitemid 29127256)
46. Bachhawat BK, Robinson WG, Coon MJ. Enzymatic carboxylation of beta-hydroxyisovaleryl coenzyme A. J Biol Chem 1956; 219: 539-550.
47. Hong SO, Layman DK. Effects of leucine on in vitro protein synthesis and degradation in rat skeletal muscles. J Nutr 1984; 114(Suppl 7): 1204-1212. (Pubitemid 14081799)
48. Smith HJ, Wyke SM, Tisdale MJ. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res 2004; 64: 8731-8735.
49. Tisdale MJ. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol 2005; 3(Suppl 3): 209-217. (Pubitemid 40852404)
50. Eley HL, Russell ST, Tisdale MJ. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-α and angiotensin II by β-hydroxy-β-methylbutyrate. Am J Physiol Endocrinol Metab 2008; 295
51. Russell ST, Tisdale MJ. Mechanism of attenuation by beta-hydroxy-beta- methylbutyrate of muscle protein degradation induced by lipopolysaccharide. Mol Cell Biochem 2009; 330(Suppl 1-2): 171-179.
52. Jejurikar SS, Henkelman EA, Cedema PS, Marcelo CL, Urbanchek MG, Kuzon WM Jr. Aging increases the susceptibility of skeletal muscle derived satellite cells to apoptosis. Exp Gerontol. 2006; 41(Suppl. 9): 828-836
53. Krajnak K, Waugh S, Miller R, Baker B, Geronilla K, Alway SE, Cutlip RG. Proapoptotic factor Bax is increased in satellite cells in the tibialis anterior muscles of old rats. Muscle Nerve. 2006;34(Suppl 6):720-730 (Pubitemid 44877555)
54. Kornasio R, Riederer I, Butler-Browne G, Mouly V, Uni Z, Halevy O. Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2009; 1793(Suppl 5): 750-763.
55. Smith HJ, Mukerji P, Tisdale MJ. Attenuation of proteasome-induced proteolysis in skeletal muscle by beta-hydroxy-beta-methylbutyrate in cancer-induced muscle loss. Cancer Res 2005; 65(Suppl 1): 277-283. (Pubitemid 40070819)
56. Eley HL, Russell ST, Baxter JH, Mukerji P, Tisdale MJ. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. Am J Physiol Endocrinol Metab 2007; 293(Suppl 4)
57. Memmott RM, Dennis PA. Akt-dependent and - independent mechanisms of mTOR regulation in cancer. Cell Signal 2009; 21: 656-664.
58. Jiang BH, Aoki M, Zheng JZ, Li Z, Vogt PK. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine kinase Akt/protein kinase B. Proc Natl Acad Sci USA 1999; 96: 2077-2081. (Pubitemid 29117870)
59. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001; 11: 1009-1013.
60. Mourkioti F, Rosenthal N. IGF-1, inflammation and stem cells: interactions during muscle regeneration Trends Immunol 2005 (Suppl 10): 535-542.
61. Eliakim A, Nemet D, Cooper DM. Exercise, training and the GH-IGF-I axis. In: Kraemer WJ, Rogol AD, eds. The Endocrine System in Sports and Exercise. Maiden, MA: Blackwell Publishing, 2005, 165-179.
62. Tatara MR. Neonatal programming of skeletal development in sheep is mediated by somatotrophic axis function. Exp Physiol 2008; 93(Suppl 6): 763-772.
63. Hsieh LC, Chien SL, Huang MS, Tseng HF, Chang CK. Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pac J Clin Nutr 2006;15(Suppl 4): 544-550.
64. Nissen S, Sharp RL, Panton L, Vukovich M, Trappe S, Fuller JC. β-hydroxy-β-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. Hum Nutr Metab 2000; 130(Suppl 8): 1937-1945. (Pubitemid 30497524)
65. Ditscheid B, Fünfstück R, Busch M, Schubert R, Gerth J, Jahreis G. Effect of L-methionine supplementation on plasma homocysteine and other free amino acids: a placebo-controlled double-blind cross-over study. Eur J Clin Nutr 2005; 59(Suppl 6): 768-775. (Pubitemid 40894941)